{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:47:30Z","timestamp":1792795650724,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.humpath.2021.08.004","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T04:57:16Z","timestamp":1629262636000},"page":"88-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus\u2013associated nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0031-0001","authenticated-orcid":false,"given":"Kartik","family":"Viswanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1036-6367","authenticated-orcid":false,"given":"Peter M.","family":"Sadow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2021.08.004_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.humpath.2021.08.004_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.humpath.2021.08.004_bib3","doi-asserted-by":"crossref","first-page":"14121","DOI":"10.1038\/ncomms14121","article-title":"Exome and genome sequencing of nasopharynx cancer identifies NF-kappaB pathway activating mutations","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2021.08.004_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10070210","article-title":"Genomic landscapes of EBV-associated nasopharyngeal carcinoma vs. HPV-associated head and neck cancer","volume":"10","author":"Ngan","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2021.08.004_bib5","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.1073\/pnas.1607606113","article-title":"Whole-exome sequencing identifies multiple loss-of-function mutations of NF-kappaB pathway regulators in nasopharyngeal carcinoma","volume":"113","author":"Zheng","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2021.08.004_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41467-020-20308-8","article-title":"Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy","volume":"12","author":"Lechner","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2021.08.004_bib7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/bbrc.1993.1412","article-title":"Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation","volume":"192","author":"Patel","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.humpath.2021.08.004_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s12105-021-01329-1","article-title":"SSTR2 expression in olfactory neuroblastoma: clinical and therapeutic implications","author":"Cracolici","year":"2021","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2021.08.004_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.humpath.2018.05.013","article-title":"Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature","volume":"79","author":"Czapiewski","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.08.004_bib10","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2454::AID-IMMU2454>3.0.CO;2-H","article-title":"SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release","volume":"29","author":"Elliott","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.humpath.2021.08.004_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gut.50.1.52","article-title":"Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies","volume":"50","author":"Kulaksiz","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2021.08.004_bib12","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/bjc.2016.377","article-title":"Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours","volume":"115","author":"Childs","year":"2016","journal-title":"Br J Canc"},{"key":"10.1016\/j.humpath.2021.08.004_bib13","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1677\/ERC-09-0078","article-title":"Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors","volume":"17","author":"Kwekkeboom","year":"2010","journal-title":"Endocr Relat Canc"},{"key":"10.1016\/j.humpath.2021.08.004_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ons\/opy028","article-title":"Neuroradiological and neuropathological changes after 177Lu-octreotate peptide receptor radionuclide therapy of refractory esthesioneuroblastoma","volume":"15","author":"Schneider","year":"2018","journal-title":"Oper Neurosurg (Hagerstown)"},{"key":"10.1016\/j.humpath.2021.08.004_bib15","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/cncr.30570","article-title":"TRAF3\/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma","volume":"123","author":"Hajek","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2021.08.004_bib16","series-title":"WHO classification of head and neck tumours","author":"El-Naggar","year":"2017"},{"key":"10.1016\/j.humpath.2021.08.004_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ajcp\/aqaa201","article-title":"Clinicopathologic features of peripheral T-cell lymphoma in sub-saharan africa","volume":"156","author":"Fitzpatrick","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2021.08.004_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.humpath.2017.02.021","article-title":"RNA chromogenic in situ hybridization assay with clinical automated platform is a sensitive method in detecting high-risk human papillomavirus in squamous cell carcinoma","volume":"63","author":"Mendez-Pena","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.08.004_bib19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.humpath.2014.01.006","article-title":"p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases","volume":"45","author":"Lee","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.08.004_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2011.12.023","article-title":"Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization","volume":"425","author":"Vandermark","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.humpath.2021.08.004_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000381062","article-title":"Somatostatin receptors 2A and 5 are expressed in Merkel cell carcinoma with No association with disease severity","volume":"101","author":"Gardair","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.humpath.2021.08.004_bib22","unstructured":"The human protein Atlas [internet]. Human Protein Somatostatin Receptor 2; SSTR2. https:\/\/www.proteinatlas.org\/ENSG00000180616-SSTR2\/tissue.%2020"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:39:01Z","timestamp":1758645541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817721001477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":22,"alternative-id":["S0046817721001477"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2021.08.004","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus\u2013associated nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2021.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}